Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Alaunos Therapeutics Inc.’s current trading price is -85.04% away from its 52-week high, while its distance from the 52-week low is 32.80%. The stock’s price range during this period has varied between $0.45 and $4.01. The company, active in the Healthcare sector, saw a trading volume of around 0.74 million for the day, considerably higher average daily volume of 0.62 million observed over the last three months.
The current stock price for Alaunos Therapeutics Inc. (TCRT) is $0.60. The stock experienced a significant increase during the last trading session, reaching $0.647 after opening at $0.641. It dipped to a low of $0.60 before ultimately closing at $0.64.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Alaunos Therapeutics Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $4.01 on 09/09/22, with the lowest value being $0.45 on 03/20/23.
How Financial Performance Impacts Market Capitalization
Alaunos Therapeutics Inc. (TCRT) has experienced a quarterly rise of 0.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 138.57M and boasts a workforce of 34 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6152, with a change in price of +0.0384. Similarly, Alaunos Therapeutics Inc. recorded 752,091 in trading volume during the last 100 days, posting a change of +6.84%.
How TCRT’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TCRT stands at 0.37. Similarly, the long-term debt-to-equity ratio is also 0.00.
TCRT Stock Stochastic Average
As of today, the raw stochastic average of Alaunos Therapeutics Inc. over the past 50 days is 59.71%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 55.25%. Additionally, the Stochastic %K and %D values for the company were 65.91% and 66.12%, respectively, over the past 20 days.
TCRT Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -7.56% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -38.35%. Over the past 30 days, the price of TCRT has fallen by 15.70%. And in the last five days, it has fallen by -3.23%.
